Benjamin Croll, MD, a Urologic Oncology Fellow at Fox Chase Cancer Center, discussed with OncLive research he presented during the American Urological Association (AUA) 2026 Annual Meeting that focused on understanding tumor response to systemic therapy in renal cell carcinoma.